Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome

被引：2

作者：

Unverdi, Selman ^{[1
]}

Ceri, Mevlut ^{[1
]}

Koklu, Seyfettin ^{[2
]}

Unverdi, Hatice ^{[3
]}

Kocak, Erdem ^{[2
]}

Duranay, Murat ^{[1
]}

机构：

[1] Ankara Educ & Training Hosp, Dept Nephrol, Ankara, Turkey

[2] Ankara Educ & Training Hosp, Dept Gastroenterol, Ankara, Turkey

[3] Ankara Univ, Sch Med, Dept Pathol, TR-06100 Ankara, Turkey

来源：

ANNALS OF HEPATOLOGY | 2011年 / 10卷 / 03期

关键词：

FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HBV-ASSOCIATED NEPHROPATHY; LAMIVUDINE;

D O I：

10.1016/S1665-2681(19)31554-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：372 / 373

页数：2

共 7 条

[1]

Herberth J, 2006, CLIN NEPHROL, V65, P380

[2] Lamivudine and HBV-associated nephropathy [J].

Izzedine, H ;

Massard, J ;

Poynard, T ;

Deray, G .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (03) :828-829

[3] Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature [J].

Khaira, Ambar ;

Upadhyay, Bala Krishna ;

Sharma, Alok ;

Das, Prasenjit ;

Mahajan, Sandeep ;

Makhariya, Govind ;

Dinda, Amit K. ;

Agarwal, Sanjay K. ;

Tiwari, Suresh C. .

CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2009, 13 (04) :373-377

[4] Viral nephropathy [J].

Lai, ASH ;

Lai, KN .

NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (05) :254-262

[5] Long-term lamivudine therapy is not reasonable for HBV-associated nephropathy [J].

Lai, Ming-Yu ;

Yang, Wu-Chang ;

Lee, Shon-Dong ;

ng, Yee-Yu Ng .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (06) :1740-1741

[6]

Sakallioglu O, 2005, J NEPHROL, V18, P433

[7]

Takaki Akinobu, 2002, Nihon Jinzo Gakkai Shi, V44, P806

← 1 →